Chances in Portal System Flow After Two Bariatric Procedures

Portal vein thrombosis

PADUA PREDICTION SCORE in Cirrhotic Patients Freiburg TIPS Registry Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients With Liver Cirrhosis Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause. IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation HAIC Combine With Lenvatinib and Camrelizumab for Advanced HCC With PVTT Living Donor Liver Transplantation to Patients With Portal Vein Thrombosis Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients Safety of Anticoagulant Therapy After Variceal Band Ligation Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism Vienna Vascular Liver Disease Study EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC With Major Portal Vein Tumor Thrombosis Chances in Portal System Flow After Two Bariatric Procedures Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT Neo-TACE-HAIC for PVTT-HCC Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver Anticoagulation Post Laparoscopic Splenectomy TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV Role of EUS Guided FNA of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular Carcinoma The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis：A Multicenter RCT Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study. Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis. Clinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPS TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis The Effect of Rifaximin on Portal Vein Thrombosis